Acute Concussion Management in Emergency Medicine with 7T MRI: a Feasibility Study
Launched by NHS GREATER GLASGOW AND CLYDE · Feb 11, 2025
Trial Information
Current as of September 07, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Acute Concussion Management in Emergency Medicine with 7T MRI: a Feasibility Study," is focused on understanding how a special type of brain scan called a 7T MRI can show changes in the brain after a concussion. Researchers want to see if there are differences in the brain images of patients who fully recover from a concussion compared to those who continue to have symptoms about 28 days after their injury. The study will include adults aged 18 to 40 who come to the Emergency Department within 96 hours of a head injury and have had a normal CT scan of their brain.
If you or someone you know has had a head injury and meets these criteria, you might be eligible to participate. During the study, participants will undergo a 7T MRI scan to help researchers learn more about how concussions affect the brain. This research could be important for improving how we understand and treat concussions in the future. It's important to note that the trial is not yet recruiting participants, but it aims to provide valuable insights into concussion management.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Isolated head trauma
- • 2. Initial review within 96h of injury
- • 3. No acute findings on CT head
- • 4. Aged 18-40 years
- Exclusion Criteria:
- • 1. Patient unable to give informed consent
- • 2. Patient unable to speak and understand English
- • 3. Patients where alternative diagnosis cannot be excluded
- • 4. Polytrauma
- • 5. Contra-indication to MRI
- • 6. BMI \>40 or unable to comfortably lie on MRI scanner
- • 7. Pregnant
- • 8. Major confounding neurological disease e.g Multiple sclerosis, Stroke, Parkinson's Disease.
- • 9. Patient participation in other research studies concurrently
About Nhs Greater Glasgow And Clyde
NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported